MX9304349A - Vacuna antirrabica no virulenta. - Google Patents

Vacuna antirrabica no virulenta.

Info

Publication number
MX9304349A
MX9304349A MX9304349A MX9304349A MX9304349A MX 9304349 A MX9304349 A MX 9304349A MX 9304349 A MX9304349 A MX 9304349A MX 9304349 A MX9304349 A MX 9304349A MX 9304349 A MX9304349 A MX 9304349A
Authority
MX
Mexico
Prior art keywords
virulent
vaccine
antirrabic
codon
nucleotides
Prior art date
Application number
MX9304349A
Other languages
English (en)
Inventor
Patrice Coulon
Florence Lafay
Jacqueline Benejean
Anne Flamand
Marie-Christine Tuffereau
Original Assignee
Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac filed Critical Virbac
Publication of MX9304349A publication Critical patent/MX9304349A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La invención tiene por objeto una vacuna antirrábica no virulenta, que está constituída de un mutante no virulento de una cepa SAD del virus rábico, cuya glicoproteína posee en la posición 333 un aminoácido natural, cuyo codón difiere de aquéllos de la arginina en al menos dos nucleótidos.
MX9304349A 1992-07-20 1993-07-19 Vacuna antirrabica no virulenta. MX9304349A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9208947A FR2693655B1 (fr) 1992-07-20 1992-07-20 Vaccin antirabique avirulent.

Publications (1)

Publication Number Publication Date
MX9304349A true MX9304349A (es) 1994-06-30

Family

ID=9432070

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304349A MX9304349A (es) 1992-07-20 1993-07-19 Vacuna antirrabica no virulenta.

Country Status (20)

Country Link
US (1) US5853735A (es)
EP (1) EP0583998B1 (es)
AT (1) ATE175877T1 (es)
BG (1) BG61066B1 (es)
BR (1) BR9302910A (es)
CA (1) CA2100591C (es)
CZ (1) CZ283400B6 (es)
DE (1) DE69323130T2 (es)
FI (1) FI933210A (es)
FR (1) FR2693655B1 (es)
HR (1) HRP931065B1 (es)
HU (1) HU219266B (es)
MA (1) MA22938A1 (es)
MX (1) MX9304349A (es)
PL (1) PL172853B1 (es)
RO (1) RO112582B1 (es)
RU (1) RU2128519C1 (es)
SI (1) SI9300392A (es)
SK (1) SK280104B6 (es)
TN (1) TNSN93083A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE356202T1 (de) * 1998-11-27 2007-03-15 Intervet Int Bv Attenuierte stabile tollwutvirusmutante und lebende impfstoffe
ATE303376T1 (de) 1999-06-03 2005-09-15 Nippon Suisan Kaisha Ltd Tricyclische kondensierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung
WO2001070932A2 (en) 2000-03-23 2001-09-27 Thomas Jefferson University Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife
NZ531025A (en) 2001-07-20 2005-08-26 Univ Georgia Res Found Vaccine comprising a mutant rabies virus N protein which has an amino acid other than serine at position 389 and possibly one or more other mutations within the N protein
ATE307606T1 (de) * 2001-10-04 2005-11-15 Ct Voor Onderzoek In Diergenee Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung
CA2463090C (en) * 2001-10-10 2012-06-12 Thomas Jefferson University Recombinant rabies vaccine and methods of preparation and use
EP1415665A3 (en) * 2002-11-01 2004-06-30 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. BHV5 mutants
ATE469964T1 (de) 2004-07-12 2010-06-15 Univ Jefferson Zusammensetzungen mit rekombinantem tollwutvirus
EP1945780B1 (en) 2005-10-14 2015-09-16 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Rabies virus vector systems and compositions and methods thereof
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique
RU2694836C1 (ru) * 2018-12-14 2019-07-17 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ получения антигена вируса бешенства для серологической диагностики

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent

Also Published As

Publication number Publication date
SK280104B6 (sk) 1999-08-06
FR2693655B1 (fr) 1994-10-14
US5853735A (en) 1998-12-29
BR9302910A (pt) 1994-02-16
PL299739A1 (en) 1994-01-24
MA22938A1 (fr) 1994-04-01
EP0583998B1 (fr) 1999-01-20
RO112582B1 (ro) 1997-11-28
HRP931065A2 (en) 1995-02-28
HRP931065B1 (en) 1999-12-31
TNSN93083A1 (fr) 1994-03-17
FI933210A (fi) 1994-01-21
CA2100591C (en) 2003-02-18
DE69323130T2 (de) 1999-06-17
CZ140293A3 (en) 1994-02-16
CZ283400B6 (cs) 1998-04-15
ATE175877T1 (de) 1999-02-15
BG97964A (bg) 1994-04-29
PL172853B1 (pl) 1997-12-31
HUT69961A (en) 1995-09-28
FR2693655A1 (fr) 1994-01-21
SI9300392A (en) 1994-06-30
FI933210A0 (fi) 1993-07-14
DE69323130D1 (de) 1999-03-04
SK76193A3 (en) 1994-06-08
CA2100591A1 (en) 1994-01-21
HU219266B (en) 2001-03-28
RU2128519C1 (ru) 1999-04-10
HU9302091D0 (en) 1993-11-29
BG61066B1 (bg) 1996-10-31
EP0583998A1 (fr) 1994-02-23

Similar Documents

Publication Publication Date Title
DE69332831T2 (de) Rekombinanter schweinepocken-virus
HUP9802217A2 (hu) Rekombináns MVA-vírus és alkalmazása
MX9304349A (es) Vacuna antirrabica no virulenta.
ATE352557T1 (de) Rekombinantes nukleoprotein von newcastle- krankheitsvirus als markierungsimpfstoff
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
RU93048174A (ru) Авирулентная вакцина против бешенства и способ ее получения
DE3853672T2 (de) Nichtzurückschlagende RNS-Viren.
ES2058570T3 (es) Procedimiento para la obtencion de una vacuna antirrabica no virulenta.
DE69433760D1 (de) Gegen mumps impfstoff, das ein virus des jeryl-lynn stammes enthält
SE9600436D0 (sv) Vaccine against hantavirus
ES2042481T1 (es) Peptidos sinteticos que derivan del antigeno hbc del virus de la hepatitis b.
ES2084587T3 (es) Arn virus no revertientes.
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
YU50393A (sh) Nova vakcina protiv besnila
TH45960EX (th) วัคซีนต่อต้านโรคพิษสุนัขบ้าที่ไม่ทำให้เกิดโรค